by AIP Online Bureau | May 19, 2024 | Indian News, Regulation, Risk Management
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote New...
by AIP Online Bureau | Mar 27, 2023 | Indian News, Non-Life, Reinsurance, Risk Management
While the drugmaker is unable to determine other impacts of the breach, including cost to maintain insurance coverage and possibility of litigation, it said there would be expenses linked to the incident. Mumbai: Sun Pharmaceutical Industries expects revenue to fall...
by AIP Online Bureau | Aug 15, 2022 | Eco/Invest/Demography, Health, Indian News, Non-Life, Reinsurance
The affected lot has been produced at the company’s Halol plant in Gujarat and distributed in the US by Cranbury-based Sun Pharmaceutical Industries, Inc New Delhi: Leading generic drug makers Glenmark, Sun Pharma, Dr Reddy’s and Jubilant Cadista are...
